Using numerical modeling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sample

Jean-Pierre Boissel, David Pérol, Hervé Décousus, Ingrid Klingmann, Marc Hommel
doi: https://doi.org/10.1101/2021.01.19.21250091

Article usage

Article usage: January 2021 to June 2025

AbstractFullPdf
Jan 2021319040
Feb 2021270432
Mar 2021450240
Apr 2021245036
May 2021470541
Jun 2021849343
Jul 2021930547
Aug 202110233769
Sep 2021713647
Oct 20211521458
Nov 2021117856
Dec 2021101137
Jan 202210199
Feb 202211226
Mar 202210665
Apr 20224326
May 202245011
Jun 202244212
Jul 20223704
Aug 20222933
Sep 202233412
Oct 20223808
Nov 20222803
Dec 20221815
Jan 20231741
Feb 20231784
Mar 20234123
Apr 20232624
May 20231313
Jun 2023943
Jul 2023825
Aug 202320108
Sep 20231647
Oct 20231037
Nov 202323149
Dec 20231523
Jan 20241124
Feb 202419312
Mar 2024161311
Apr 202417119
May 20241466
Jun 202427118
Jul 20241477
Aug 202415612
Sep 20242914
Oct 20241261
Nov 202415412
Dec 20241306
Jan 20252435
Feb 202520195
Mar 2025343315
Apr 202524813
May 2025261019
Jun 20251011
Back to top
Posted July 30, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Using numerical modeling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sample
Jean-Pierre Boissel, David Pérol, Hervé Décousus, Ingrid Klingmann, Marc Hommel
medRxiv 2021.01.19.21250091; doi: https://doi.org/10.1101/2021.01.19.21250091
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area